ACCEPTANCE OF INDIRECT COMPARISONS IN THE GERMAN EARLY BENEFIT ASSESSMENT

被引：0
|
作者：
Berkemeier, F. [1 ]
Bless, H. [1 ]
Reindl, S. [2 ]
Ballhausen, A. [3 ]
Maltz, A. [2 ]
机构：
[1] IGES Inst GmbH, Berlin, Germany
[2] IGES Inst GmbH, Nurnberg, Germany
[3] IGES Inst GmbH, Hamburg, Germany
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.1597
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP64
引用
收藏
页码：A663 / A663
页数：1
相关论文
共 50 条
  • [1] RELEVANCE OF INDIRECT COMPARISONS IN THE GERMAN EARLY BENEFIT ASSESSMENT (AMNOG)
    Lebioda, A.
    Gasche, D.
    Dippel, F. W.
    Plantoer, S.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A484 - A485
  • [2] Indirect Comparisons in Early Benefit Assessment
    Moeser, G.
    Ecker, C.
    [J]. GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2013, 18 (05): : 235 - 243
  • [3] INDIRECT COMPARISONS IN BENEFIT ASSESSMENT
    Kuehnast, S.
    Schiffner-Rohe, J.
    Rahnenfuehrer, J.
    Leverkus, R.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A721 - A721
  • [4] Relevance of indirect comparisons in the German early benefit assessment and in comparison to HTA processes in England, France and Scotland
    Lebioda A.
    Gasche D.
    Dippel F.-W.
    Theobald K.
    Plantör S.
    [J]. Health Economics Review, 4 (1)
  • [5] KEY CRITERIA FOR ACCEPTANCE OF INDIRECT COMPARISONS IN THE BENEFIT ASSESSMENT BY THE G-BA AND BY THE IQWIG
    Bonduelle, D.
    Fischer, T.
    Schuh, I
    Schwarz, S.
    [J]. VALUE IN HEALTH, 2019, 22 : S608 - S609
  • [6] Analysis of acceptance rate and rationales for rejection of indirect comparisons in IQWiG's benefit assessments
    Werner, Sebastian
    Lechterbeck, Lisa
    Rasch, Andrej
    Merkesdal, Sonja
    Ruof, Joerg
    [J]. GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2020, 25 (01): : 24 - 36
  • [7] IMPLICATIONS OF EU HTA ON ACCEPTANCE OF INDIRECT COMPARISONS IN NATIONAL ASSESSMENTS
    Ecker, T.
    Kandola, S.
    Marx, E.
    Brozek, A.
    Ahrens, L.
    Ritz-Jansen, K.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S268 - S269
  • [8] PRICE CHANGES AFTER INDICATION EXTENSION IN THE GERMAN EARLY BENEFIT ASSESSMENT
    Freiberg, M.
    Karimi, M.
    Bockmann, D.
    Wagner, P.
    [J]. VALUE IN HEALTH, 2020, 23 : S466 - S466
  • [9] HEALTH-RELATED QUALITY OF LIFE IN THE GERMAN EARLY BENEFIT ASSESSMENT
    Barth, M.
    Kramer, L.
    Thaa, B.
    Moos, M.
    Esser, M.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S320 - S320
  • [10] AN EARLY ASSESSMENT OF THE GERMAN FEDERAL JOINT COMMISSION RESOLUTIONS OF ADDITIONAL CLINICAL BENEFIT
    McBride, D.
    Kilburg, A.
    Mauskopf, J.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A311 - A311
12345